International Society For Antiviral Research
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 345,900 | 269,407 | 76,493 | 36.0 | 0% |
| 2012 | 380,915 | 379,753 | 1,162 | 26.0 | 0% |
| 2013 | 353,099 | 412,964 | −59,865 | 21.8 | 0% |
| 2014 | 361,954 | 399,964 | −38,010 | 21.5 | 0% |
| 2015 | 321,596 | 347,102 | −25,506 | 23.9 | 0% |
| 2016 | 316,498 | 356,293 | −39,795 | 21.0 | 0% |
| 2017 | 349,524 | 326,526 | 22,998 | 23.8 | 0% |
| 2018 | 339,838 | 371,619 | −31,781 | 19.3 | 0% |
| 2019 | 354,236 | 348,910 | 5,326 | 22.6 | 0% |
| 2020 | 140,953 | 211,890 | −70,937 | 37.2 | 0% |
| 2021 | 166,963 | 185,489 | −18,526 | 43.5 | 0% |
| 2022 | 364,006 | 453,363 | −89,357 | 13.7 | 0% |
| 2023 | 367,501 | 403,525 | −36,024 | 14.8 | 0% |
In its most recent public year (2023), this organization spent $36,024 more than it brought in. Its reserves stood at about 14.8 months of spending, down from 36 in 2011. Staff pay was 0% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
International Society For Antiviral Research's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works